Subtopic Deep Dive

← Plant Toxicity and Pharmacological Properties

Pyrrolizidine Alkaloids Risk Assessment Food Herbal Medicines
Research Guide

What is Pyrrolizidine Alkaloids Risk Assessment Food Herbal Medicines?

Pyrrolizidine alkaloids risk assessment evaluates exposure models, benchmark dose analyses, and margins of exposure for PA contaminants in foods, herbal teas, infusions, and supplements to protect consumer health.

This subtopic focuses on analytical detection methods and regulatory benchmarks for PAs from plants like Symphytum species contaminating honey, tea, and herbal products. Key studies include EFSA's 2017 opinion by Knutsen et al. (235 citations) on PA risks in food supplements and Schramm et al. (2019, 166 citations) on PA biosynthesis and occurrence in crops. Over 1,000 papers address PA toxicology since 1990.

Curated Papers

Key Challenges

Why It Matters

EFSA's framework by Knutsen et al. (2017) supports EU regulations limiting PA levels in honey to 1 µg/kg, preventing hepatotoxicity cases from contaminated teas. Huxtable (1992, 166 citations) highlighted risks of herbal remedies like comfrey, leading to bans in multiple countries. Stickel and Seitz (2000, 156 citations) documented veno-occlusive disease from PA ingestion, informing global standards for food safety and supplement labeling.

Key Research Challenges

PA Detection Limits

Analytical methods struggle with low PA concentrations in complex matrices like honey and herbal infusions. Knutsen et al. (2017) noted LC-MS/MS benchmarks but variability in validation across labs. Standardization remains inconsistent per van den Berg et al. (2011).

Exposure Modeling Variability

Consumer exposure varies by diet and product contamination rates, complicating margin-of-exposure calculations. EFSA models by Knutsen et al. (2017) use benchmarks but lack data on chronic low-dose effects. Neuman et al. (2015) highlight gaps in herbal supplement intake data.

Regulatory Harmonization Gaps

Differing global limits hinder trade; EU caps PAs in tea at 400 ng/kg while others lack standards. Schramm et al. (2019) call for unified risk thresholds based on genotoxicity data. Stickel et al. (2000) report inconsistent enforcement leading to poisonings.

Essential Papers

Risks for human health related to the presence of pyrrolizidine alkaloids in honey, tea, herbal infusions and food supplements

Helle Katrine Knutsen, Jan Alexander, Lars Barregård et al. · 2017 · EFSA Journal · 235 citations

EFSA was asked by the European Commission to deliver a scientific opinion on the risks for human health related to the presence of pyrrolizidine alkaloids (PAs) in honey, tea, herbal infusions and ...

Pyrrolizidine Alkaloids: Biosynthesis, Biological Activities and Occurrence in Crop Plants

Sebastian Schramm, Nikolai Köhler, Wilfried Rozhon · 2019 · Molecules · 166 citations

Pyrrolizidine alkaloids (PAs) are heterocyclic secondary metabolites with a typical pyrrolizidine motif predominantly produced by plants as defense chemicals against herbivores. They display a wide...

The Myth of Beneficent Nature: The Risks of Herbal Preparations

Ryan J. Huxtable · 1992 · Annals of Internal Medicine · 166 citations

Editorials15 July 1992The Myth of Beneficent Nature: The Risks of Herbal PreparationsRyan J. Huxtable, PhDRyan J. Huxtable, PhDSearch for more papers by this authorAuthor, Article, and Disclosure I...

The efficacy and safety of comfrey

Felix Stickel, Helmut K. Seitz · 2000 · Public Health Nutrition · 156 citations

Abstract Herbal medication has gathered increasing recognition in recent years with regard to both treatment options and health hazards. Pyrrolizidine alkaloids have been associated with substantia...

Hepatotoxicity of botanicals

Felix Stickel, Gerlinde Egerer, Helmut K. Seitz · 2000 · Public Health Nutrition · 153 citations

Abstract Objective Hepatic impairment resulting from the use of conventional drugs is widely acknowledged, but there is less awareness of the potential hepatotoxicity of herbal preparations and oth...

Hepatotoxicity of Pyrrolizidine Alkaloids

Manuela G. Neuman, Lawrence Cohen, Mihai Opris et al. · 2015 · Journal of Pharmacy & Pharmaceutical Sciences · 108 citations

PURPOSE: This article aimed 1) to review herbal medicine containing pyrrolizidine alkaloids (PA)-induced toxicities of the liver; 2) to encourage the recognition and prevention of common problems e...

Topical herbal therapies for treating osteoarthritis

Melainie Cameron, S. Chrubasik · 2013 · Cochrane Database of Systematic Reviews · 101 citations

Although the mechanism of action of the topical medicinal plant products provides a rationale basis for their use in the treatment of osteoarthritis, the quality and quantity of current research st...

Reading Guide

Foundational Papers

Read Huxtable (1992, 166 citations) first for herbal risk overview; Stickel and Seitz (2000, 156 citations) next for comfrey PA cases; van den Berg et al. (2011, 95 citations) for food supplement assessments.

Recent Advances

Study Knutsen et al. (2017, 235 citations) EFSA benchmarks; Schramm et al. (2019, 166 citations) on biosynthesis; Salehi et al. (2019, 88 citations) on Symphytum applications.

Core Methods

Core techniques: LC-MS/MS quantification (Knutsen 2017), benchmark dose analysis (van den Berg 2011), genotoxicity risk modeling (Neuman 2015), exposure margin calculations (EFSA standards).

How PapersFlow Helps You Research Pyrrolizidine Alkaloids Risk Assessment Food Herbal Medicines

Discover & Search

Research Agent uses searchPapers('pyrrolizidine alkaloids risk assessment honey tea') to retrieve Knutsen et al. (2017, 235 citations), then citationGraph reveals EFSA derivatives and findSimilarPapers uncovers van den Berg et al. (2011) on genotoxic risks in supplements.

Analyze & Verify

Analysis Agent applies readPaperContent on Knutsen et al. (2017) to extract exposure data, verifyResponse with CoVe checks PA benchmark doses against Schramm et al. (2019), and runPythonAnalysis plots dose-response curves using NumPy/pandas; GRADE grading scores EFSA evidence as high-quality for regulatory use.

Synthesize & Write

Synthesis Agent detects gaps in chronic exposure models from Huxtable (1992) vs. recent EFSA data, flags contradictions in comfrey safety per Stickel and Seitz (2000); Writing Agent uses latexEditText for risk tables, latexSyncCitations for 20+ refs, latexCompile for PDF, and exportMermaid for PA metabolism diagrams.

Use Cases

"Model PA exposure from daily herbal tea consumption using EFSA data."

Research Agent → searchPapers → readPaperContent (Knutsen 2017) → Analysis Agent → runPythonAnalysis (pandas dose-response model) → matplotlib exposure plot output.

"Draft LaTeX report on PA risks in comfrey supplements with citations."

Synthesis Agent → gap detection (Stickel 2000 + Neuman 2015) → Writing Agent → latexEditText (add sections) → latexSyncCitations (10 refs) → latexCompile → PDF report output.

"Find code for PA LC-MS/MS detection analysis from papers."

Research Agent → citationGraph (Schramm 2019) → paperExtractUrls → Code Discovery → paperFindGithubRepo → githubRepoInspect → R script for peak quantification output.

Automated Workflows

Deep Research workflow scans 50+ PA papers via searchPapers, structures EFSA-style risk report with GRADE scores in 7 steps. DeepScan analyzes contamination datasets from van den Berg et al. (2011) with CoVe checkpoints and Python stats. Theorizer generates hypotheses on PA bioactivation from Neuman et al. (2015) metabolism data.

Try Doxa for Pyrrolizidine Alkaloids Risk Assessment Food Herbal Medicines Research

Frequently Asked Questions

What defines pyrrolizidine alkaloids risk assessment?

It develops exposure models and margins of exposure for PA contaminants in foods and herbal medicines, as defined in Knutsen et al. (2017) EFSA opinion.

What are main methods for PA risk assessment?

Methods include LC-MS/MS detection, benchmark dose modeling, and margin-of-exposure calculations per Knutsen et al. (2017) and van den Berg et al. (2011).

What are key papers on PA risks?

Top papers: Knutsen et al. (2017, 235 citations) on food risks; Huxtable (1992, 166 citations) on herbal dangers; Stickel and Seitz (2000, 156 citations) on comfrey toxicity.

What open problems exist in PA research?

Challenges include chronic low-dose effects modeling, global analytical standardization, and herbal supplement intake variability, per Schramm et al. (2019) and Neuman et al. (2015).